Australian Drug Evaluation Committee 2340367 158662037 2007-09-18T05:38:49Z 150.203.36.136 The '''Australian Drug Evaluation Committee''' or '''ADEC''', is a [[committee]] that provides independent scientific advice to the [[Government of Australia|Australian Government]] regarding therapeutic [[medication|drugs]]. The committee was originally formed in [[1963]] and more recently authorised under the ''Therapeutic Goods Act 1989 (Cth)'' as part of the [[Therapeutic Goods Administration]] (TGA). ADEC provides advice to the Minister for Health and Ageing and the Secretary of the Department of Health on: *quality, risk-benefit, effectiveness and accessibility of drugs referred to ADEC for evaluation *medical and scientific evaluations of applications for registration of new drugs An important role of ADEC is the classification of drugs in Australia into [[Pregnancy category|pregnancy categories]]. There two main subcommittees of ADEC which are responsible for specific aspects of drug regulation in Australia: *the [[Adverse Drug Reactions Advisory Committee]] (ADRAC); *the Pharmaceutical Subcommittee – which makes recommendations to ADEC on the [[pharmaceutical]] aspects ([[chemistry]], [[quality control]], [[pharmacokinetics]], etc) of drugs proposed for registration ==See also== *[[International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use]] (ICH) *[[Food and Drug Administration]] (FDA, USA) *[[European Medicines Agency]] (EMEA, EU) *[[Ministry of Health, Labour and Welfare (Japan)]] ==External links== *[http://www.tga.gov.au/docs/html/adec/adec.htm ADEC website] [[Category:Evaluation]] [[category:Government entities of Australia]] [[Category:Healthcare in Australia]] [[Category:Pharmaceuticals policy]]